“…The frequency of peripheral CD27ϩ,CD19ϩ memory B cells was significantly reduced in patients with primary SS compared with healthy control subjects (mean Ϯ SD 13.3 Ϯ 12.3% versus 25.6 Ϯ 7.2%; P Յ 0.0014), whereas the frequency of CD19ϩ,CD27Ϫ naive B cells was significantly enhanced in patients with primary SS (mean Ϯ SD 86.1 Ϯ 12.0% versus 74.4 Ϯ 7.2%; P Յ 0.0014) as reported previously (6,8,9). To ensure that these alterations in patients with primary SS did not further influence the analyses, either CD19ϩ,CD27Ϫ or CD19ϩ,CD27ϩ B cells were gated, and the chemokine receptor expression was subsequently analyzed within each subpopulation ( Figures 1A and B).…”